Kodandaram Sumalatha

  • Citations Per Year
Learn More
Tamoxifen therapy for the treatment of hormone responsive breast cancer has limitations due to acquired resistance in the case of recurrences. Embelin, a known inhibitor of X-linked inhibitor of(More)
  • 1